Ceramide Enables Fas to Cap and Kill
Overview
Affiliations
Recent studies suggest that trimerization of Fas is insufficient for apoptosis induction and indicate that super-aggregation of trimerized Fas might be prerequisite. For many cell surface receptors, cross-linking by multivalent ligands or antibodies induces their lateral segregation within the plasma membrane and co-localization into "caps" on one pole of the cell. In this study, we show that capping of Fas is essential for optimal function and that capping is ceramide-dependent. In Jurkat T lymphocytes and in primary cultures of hepatocytes, ceramide elevation was detected as early as 15-30 s and peaked at 1 min after CH-11 and Jo2 anti-Fas antibody treatment, respectively. Capping was detected 30 s after Fas ligation, peaked at 2 min, and was maintained at a lower level for as long as 30 min in both cell types. Ceramide generation appeared essential for capping. Acid sphingomyelinase -/- hepatocytes were defective in Jo2-induced ceramide generation, capping, and apoptosis, and nanomolar concentrations of C(16)-ceramide restored these events. To further explore the role of ceramide in capping of Fas, we employed FLAG-tagged soluble Fas ligand (sFasL), which binds trimerized Fas but is unable to induce capping or apoptosis in Jurkat cells. Cross-linking of sFasL with M2 anti-FLAG antibody induced both events. Pretreatment of cells with natural C(16)-ceramide bypassed the necessity for forced antibody cross-linking and enabled sFasL to cap and kill. The presence of intact sphingolipid-enriched membrane domains may be essential for Fas capping since their disruption with cholesterol-depleting agents abrogated capping and prevented apoptosis. These data suggest that capping is a ceramide-dependent event required for optimal Fas signaling in some cells.
Sharma D, Czarnota G Cancer Metastasis Rev. 2025; 44(1):39.
PMID: 40088396 DOI: 10.1007/s10555-025-10255-5.
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy.
Dorweiler T, Singh A, Ganju A, Lydic T, Glazer L, Kolesnick R Cell Metab. 2024; 36(7):1521-1533.e5.
PMID: 38718792 PMC: 11222062. DOI: 10.1016/j.cmet.2024.04.013.
Vijayaraghavan C, Raman L, Surenderan S, Kaur H, Chinambedu M, Thyagarajan S Molecules. 2024; 29(8).
PMID: 38675558 PMC: 11052367. DOI: 10.3390/molecules29081737.
Serotonin Signaling through Lipid Membranes.
Kalinichenko L, Kornhuber J, Sinning S, Haase J, Muller C ACS Chem Neurosci. 2024; 15(7):1298-1320.
PMID: 38499042 PMC: 10995955. DOI: 10.1021/acschemneuro.3c00823.
Staquicini D, Cardo-Vila M, Rotolo J, Staquicini F, Tang F, Smith T Proc Natl Acad Sci U S A. 2023; 120(34):e2220269120.
PMID: 37579172 PMC: 10450669. DOI: 10.1073/pnas.2220269120.